Hoitt Jason 4
4 · Dova Pharmaceuticals Inc. · Filed Oct 2, 2019
Insider Transaction Report
Form 4
Hoitt Jason
Chief Commercial Officer
Transactions
- Sale
Common Stock
2019-09-30$28.00/sh−2,387$66,836→ 9,970 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units.